Axite has secured €250,000 in Takeoff 2 early-stage funding, a significant step forward in their journey of innovation and growth. Meanwhile, 1NA has been honored with the prestigious 2025 CES Innovation Award, recognizing their outstanding contributions to technology and health.
These milestones reflect the spirit of ambition and innovation that defines our Leiden Bio Science Park community. Congratulations to both teams—here’s to an exciting future ahead!.
VarmX, a biotechnology company based at the Leiden Bio Science Park (LBSP), has entered into a strategic collaboration and option agreement with global biotechnology leader CSL...
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by...
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.